Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula

被引:0
|
作者
Kopp, Ryan P. [1 ,2 ]
Aganovic, Lejla [3 ,4 ]
Palazzi, Kerrin L. [1 ]
Cassidy, Fiona H. [3 ,4 ]
Sakamoto, Kyoko [1 ,2 ]
Derweesh, Ithaar H. [1 ,2 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Surg, Div Urol, La Jolla, CA 92093 USA
[2] San Diego Vet Adm Med Ctr, Surg Serv, La Jolla, CA USA
[3] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA
[4] San Diego Vet Adm Med Ctr, Serv Radiol, La Jolla, CA USA
关键词
carcinoma; renal cell; computerized tomography; diagnosis; enhancement; histology; Hounsfield unit; PATHOLOGICAL FEATURES; CORTICAL TUMORS; CORE BIOPSY; MASSES; SUNITINIB; PAPILLARY; EFFICACY; CM;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To further elucidate potential patterns of contrast enhancement for renal neoplasm subtypes, we investigated utility of contrast washout formula to differentiate renal tumor histology after multiphase computerized tomography (CT). Materials and methods: Single center retrospective cohort study of 163 patients with multiphase CT for renal masses obtained October 2007 to July 2012. Pathology confirmed clear cell (CC-RCC; n = 92), papillary (Pa-RCC; n = 43), chromophobe (Ch-RCC; n = 6), oncocytoma (OC; n = 11), or angiomyolipoma (AML; n = 11) histology. Two radiologists in consensus and blinded to histology recorded tumor size, morphology, and attenuation measurements in Hounsfield Units (HU). Data were analyzed between subgroups based on histology. Enhancement washout of the tumor was calculated by the formula (Mass nephrographic HU-Mass delayed HU)/(Mass nephrographic HU-Mass non-contrast HU) and used to calculate sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Results: Tumor size was largest among CC-RCC (p < 0.001). Homogeneous composition was more common among Pa-RCC and Ch-RCC (p < 0.001). Median washout for Ch-RCC (0.27) was significantly different from that of OC (0.54, p = 0.05). Overall 25 (15.3%) of tumors had washout < 0. Tumors with washout value < 0 were Pa-RCC 24/43 (56%), and Ch-RCC 1/6 (14%). Washout value < 0 had a specificity of 99.2% for Pa-RCC and 100% for non-CC-RCC. Washout value >= 0 had a sensitivity and NPV of 100% for CC-RCC, OC, and AML. Washout value 0 had a specificity of 35.2% and a PPV of 66.7% for CC-RCC. Conclusions: Enhancement washout value < 0 is highly specific for Pa-RCC and non-CC-RCC. Washout value 0 is highly sensitive for CC-RCC, OC, and AML while there was a significant difference in median washout between OC and Ch-RCC. Further prospective investigation is requisite to confirm these findings.
引用
收藏
页码:6790 / 6797
页数:8
相关论文
共 50 条
  • [1] DIFFERENTIATION OF NON CLEAR RENAL CELL CARCINOMA FROM CLEAR CELL RENAL CELL CARCINOMA USING CT WASHOUT FORMULA: A RETROSPECTIVE STUDY
    Kopp, Ryan P.
    Aganovic, Lejla
    Palazzi, Kerrin L.
    Derweesh, Ithaar H.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E239 - E240
  • [2] Non-clear cell renal cell carcinoma
    Ahrens, Marit
    Bergmann, Lothar
    UROLOGIE, 2024, 63 (12): : 1240 - 1245
  • [3] Non-Clear Cell Renal Cell Carcinoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 8 - 10
  • [4] Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
    Vermassen, T.
    De Meulenaere, A.
    Van de Walle, M.
    Rottey, Sylvie
    ACTA CLINICA BELGICA, 2017, 72 (01) : 12 - 18
  • [5] Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
    Xu K.Y.
    Wu S.
    Biomarker Research, 3 (1)
  • [6] The role of immunotherapy in non-clear cell renal cell carcinoma
    Climent, Carla
    Soriano, Sandra
    Bonfill, Teresa
    Lopez, Natalia
    Rodriguez, Marta
    Sierra, Marina
    Andreu, Pablo
    Fragio, Monica
    Busquets, Mireia
    Carrasco, Alicia
    Cano, Ona
    Segui, Miguel-Angel
    Gallardo, Enrique
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Updates in the Systemic Therapy Options for Clear Cell and Non-Clear Cell Renal Cell Carcinoma
    Spiess, Philippe E.
    Johnstone, Peter A. S.
    Jonasch, Eric
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5):
  • [8] Targeted therapies for non-clear renal cell carcinoma
    Eric A. Singer
    Gennady Bratslavsky
    W. Marston Linehan
    Ramaprasad Srinivasan
    Targeted Oncology, 2010, 5 : 119 - 129
  • [9] Targeted therapies for non-clear renal cell carcinoma
    Singer, Eric A.
    Bratslavsky, Gennady
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    TARGETED ONCOLOGY, 2010, 5 (02) : 119 - 129
  • [10] Renal cell carcinoma: The effect of targeted therapies on clear cell and non-clear cell histologies.
    Marascio, Joseph A.
    Rabatic, Bryan M.
    Zaenger, David
    Madden, Nicholas A.
    Marchan, Edward M.
    McDermott, David
    Misiura, Anne Kathryn
    Shaaban, Sherif
    Dasher, Byron G.
    Huang, Ke
    Pishgou, Mahboubeh
    Martin, William D.
    Aletan, Maryam
    Howington, Jed W.
    Albasheer, Ahmad M.
    Amoush, Ahmad
    Stewart, John G.
    Kong, Feng-Ming
    Ferguson, Catherine L.
    Mourad, Waleed F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)